Diet study for adult men with Crohn’s disease
Part of Digestive system clinical trials.
This study looks at how a specific amino-acid (threonine) diet affects adults with Crohn’s disease and signs of intestinal inflammation. It may help researchers understand what dietary protein needs could support more stable disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 49
- You have Crohn’s disease affecting the ileum and/or colon, and your symptoms are fairly stable (Crohn’s score 8 or less)
- You show some signs of active inflammation (for example, higher CRP in past tests), even if you’re stable
- You do not have intestinal narrowing (strictures) that would prevent eating a normal diet
- Your weight has been stable for at least 3 months, and you’re not getting food through a feeding tube
- You can follow study steps and safely eat the diet provided (including avoiding very high coffee/alcohol)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special diet using a nutritional supplement can reduce inflammation and improve symptoms in people with active Crohn's disease affecting the small intestine. It aims to see how the diet changes gut bacteria and body composition.
This study looks at how diet affects inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It may help understand if certain foods can improve symptoms.
This study tests a special liquid diet (smoothie) to treat newly diagnosed Crohn's disease in children and young adults. It aims to understand how the diet works and if it can help reduce inflammation.
This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
This study tests whether adding a special diet (called CDED) to a biologic medicine (infliximab or adalimumab) helps control Crohn's disease better than the medicine alone. It may reduce inflammation and improve symptoms.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.